Implantation of the MicroMed DeBakey VAD  by Noon, George P. et al.
hnplantation of the MicroMed DeBakey VAD 
George P. Noon, Matthias Loebe, Suellen Invin, and Javier A. Lafuente 
A xial flow primps have recently been introduced into clinical use. Although the pulsatile 1)umps com- 
monly used in the 1980s to 1990s were effective in 
providing adequate supl)ort, many advantages nmy be 
associated with tile continuous axial flow l)umps being 
developed today. TILe continuous axial flow design is 
smaller in size, requires no valves, air vent, or compli- 
ance chanlber, has fewer moving parts, has lower 
power requirements, is easier to implant and exlflant, 
makes less noise, and is less expensive, l-L
Tile MicroMed DeBakey Ventricular Assist Device 
(VAD) (MieroMed Technolo~,, Inc., Houston, TX) was 
the first of these devices implanted ill humans. 5,6 Since 
the first snccessfid implant in November 1998, more 
that 150 MicroMed DeBakey VADs have been im- 
planted worhhvide. The device has obtained CE Mark- 
ing and is now commercially available in Europe. 
In the US feasilfility trial, 25 patients have received 
tile MicroMed DeBakey VAD as of June 2002. To qual- 
ify for enrolhuent in the US trial, tile patient must be 
listed for transplant and have demonstrated profound 
cardiac failure despite maximal medical therapy or the 
use of an intra-aortic balloon pump. l-L There are no 
exclusions to implant of tile device other than those that 
wouhl typically exclude a patient from cardiac trans- 
plant. 3 
Tile device is routinely implanted as an left ventric- 
ular assist device (LVAD) using a median sternotomy. 
However, patients with l, revious sternotomies have 
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been successfully inqflanted with tile MicroMcd De- 
Bakey VAD through a left lateral thoracotomy. 
SURGICAL TECHNIQUE 
Before the start of tile ol,erative procedure, the pump 
is assembled by mounting the outflow graft onto the 
outflow end of tile pump. A flow probe is placed on tile 
outflow graft to measure i;mnl , flows after imldant. TILe 
pinup is tested by connecting the percutaneous lead to 
the controller with battery and immersing tile lmmp ill 
a dextrose 5% and water solution, z,'t The immp is 
turned on and checked for forward flow and function. 
At the time of explant for cardiac translflantation, 
the metlian sternotomy incision is opened with an os- 
cillating saw, taking care not to injure the inflow graft 
or heart. TILe ePTFE is hellfful in protecting tile heart 
and graft and also makes the dissection for exposing the 
heart less difficuh. If dissection is difficuh or bleeding 
occurs, femoral-femoral bypass can be used; otherwise, 
standard cannulation for translflant cardiolmhnonary 
bypass is performed after heparinization. The outflow 
graft is clamped, and the pmnp is stopped. A standard 
cardiectomy anti transplant are performed. TILe pump 
driveline is cut for pump and heart removal. The re- 
sidual driveline will be removed after completing the 
transplant. 
In lmtients who have had previous median sternoto- 
mies and coronary artery bypass with venous or arte- 
rial grafts, a left lateral approach is preferred to im- 
plant tile MicroMed DeBakey VAD. When using the 
thoracotomy approach, the VAD inflow canmfla is sewn 
into the ventricular apex in tile usual fashion. TILe 
outflow graft is anastamosed to tile descending thoracic 
aorta. An echocardiogram or compnted tomography 
scan is used to evaluate the descending thoracic aorta 
for atherosclerotic disease before surgery. 
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1/~ A small abdominal wall pocket is formed below the rectus muscle. For pump implantation, a median sternotomy 
incision is performed extending several inches below the xiphoid process. A small abdominal wall pocket is formed below the 
rectus muscle. The size and configuration of the pocket is determined by using the actual or mock pump as a model. To provide 
access to the left ventricular apex, the pericardium is opened, the diaphragmatic attachment to the costal margin is divided, 
and both are extended laterally beyond the apex. Meticulous hcmostasis i obtained. ~-~ Aprotinin may be administered per 
physician preference. The patient is heparinized in preparation for cardiopuhnonary bypass. The ascending aorta is 
cannulated, anti then single or double cannulation of the right atrium and cava is performed, depending on presence of a 
patent foramen ovale. If a patent foramcn ovale is detected by echocardiogram, it is repaired before be~nning the LVAD 
implant, l-t 
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1]~ A left thoracotonly extending across tile costal margin is used for exposure of tile left ventricular apex and descending 
thoracic aorta in the thoracic implant. Using this apl)roach, the patient is placed in a lateral position with the left side up. 
Doullle-lumcn intnbation is preferred. The left groin is prepared for eXllOsure of the common femoral artery and vein for 
cardiopulmonary b pass eannulation. A left anterior-lateral thoracotomy skin incision is performed, and the chest cavity is 
entered through the sixth or seventh intercostal space and extended across tile costal nlargin. Tile left hmg is collapsed, and 
the left ventricular apex is exposed by incising the pericardium. Tile descending aorta is exposed above tile diaphragm, and 
the inferior lnlhnonary ligament is divided. The upper part of the descending aorta can be usell if desired for arterial 
cannulation for extracorporeal circnlation. 
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2Ak Cardiopulmonary bypass is initiated and preparation for post-implant 
right heart bypass is performed if indicated with cannulation of the pulmonary 
artery. ~ Tile left ventricular apex is elevated, and tile insertion site of tile inflow 
cannula is selected. The apical fixation ring is sewn in place with interrupted 2-0 
or 3-0 polypropylene mattress utures with large Teflon felt pledgets, l-t Four of 
the fixation ring sutures are tied at equal spaces apart to hohl the ring in place. 
Tile remaining sutnres are left untied, and all are clamped separately in prepa- 
ration for sewing to the inflow cannula sewing ring.- 
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21]~ Tile l)Uml ) inflow cannnla is inscrtcd ill the lcft ventricular apex and sewn into 
place. Then 2-0 or 3-0 plcdgctcd I)olypropylcne sntures are lllaced in tile left ventricular 
apex to attacll tile fixation ring in tile usual fashion. Tile device is assembled, and a 
vascular clamp is applied on tile outflow graft. I leparin is mlministered, and tile patient is 
cannnlatcd and placed on cardiollulmonary bypass. Tile core is removed from tile apex, 
and the device inflow cannula is inserted into tlie left ventricle. Again, care is taken to 
obtain correct positioning of tile inflow canlmla. Tile cannula is secured using tile previ- 
ously described teclmique. Tile device is deaircd by removing anti reallplying tile vascular 
clamp froln tile outflow graft. I f  tile heart is fibrillating it is defibrillated. 
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8A In preparation for insertion of tile pump inflow eamnda, the left apex is maintained elevated. Tile heart may remain 
beating, fibrillated, or arrested. Using a scalpel with a no. 11 blade, a full-thickness cruciate incision is made inside tile apical 
ring. The ventricnlar apex is manually compressed to prevent bleeding. A round bladed coring device is inserted into tlle left 
ventricle to extract a core of the left ventricular apex. Coring of the apex can also be performed using a scalpel and scissors. 
To confirm precise apical coring and extraction, the apical tissue is removed from tile coring device and carefully examined 
for completeness. Distal  ventricular exploration is performed to evaluate the position of the core anti to ensure absence of any 
potential obstruction to inflow. Visual exploration of the ventricle nsing pump suction to evacuate blood may be necessary for 
further removal of myocardium or clot. 
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31~ A partial occlusion clamp is placed on the descending aorta. Tile vessel is opened longitudinally, and the outflow graft 
is cut to appropriate l ngth usually with a gentle curve, and if necessary, a portion of tile external graft protector is removed. 
It is important to make certain that there is adequate perfusion and oxygenation of the upper body while tile aorta is partially 
clamped. Tile graft is sewn end-to-side to tile aorta using 4-0 running polypropylene suture. The heart is filled with blood, and 
the device is again carefully de-aired. The partial occluding aortic clamp is removed, and the VAD is started. Meticulous 
hemostasis obtained. The driveline is tunneled to the right side of the abdomen where it exits through the skin. The pump 
is connected to the controller and CDAS (Clinical Data Acquisition System) and started. 
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4A Tile Imml ) outflow graft is clamped, and tile inflow cammla is inserted into tile left ventricular apex. 1-t Tile 2 
purse-string sutures on the apical fixation ring are tied. Proper placement of the inflow eammla inside the ventricle is 
imperative. Tile goal is to place tile inflow cannula so that it is angled toward the aortic valve without being directed toward 
the sel,tuin or free wall of the myoeardimn. The inflow eannula position can be adjusted by moving the body of the l)nlnp in 
the pocket. The canmlla opening must be clear of any ventricular tissue. Using the previously placed polypropylene sutures, 
the suture ring on the inflow canuula is sewn to the apical fixation r ing) -4 The pump and left ventricle are de-aired l,y allowing 
the ventricle to fill with blood. Tile imml, and outflow graft are elevated and filled with blood from the ventricle by releasing 
and real, plying tile clamp on the outflow graft. The apical insertion site is carefltlly checked for bleeding. To ensure 
hemostasis, it may be necessary to further seal the ventricular sewing ring attachment by approximating the left ventricular 
apex anti the sewing ring with a Teflon felt strip and continuous 2-0 or 3-0 polypropylene suture. Biological glues may also be 
applied, l-, 
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L][]I]~ Tile immp and outflow graft are covered ~dth ePTFE to facilitate subsequent ransplant anti device removal. Tile 
patient is weaned from cardiopulmonary bypass; heparinization is reversed with protamine sulfate; and 2 chest tubes are 
inserted into the left chest. Tile device is covered with ePTFE, and the thoraeotomy incision is closed in the usual fashion. 
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Tile MieroMed DeBakey VAD is placed into tile abdominal pocket, anti tile 
length of tile outflow graft is measured and tr immed. Tile graft shouhl lie under  
tile right sternal border  without kinking or overstretching. A proximal,  external 
graft protector is designed to prevent graft kinking. Care is taken to ensure tllat 
tile flow probe is approximated to tile end of tile graft protector as this helps in 
proper  positioning of the outflow graft. It may be necessary to create a subcostal 
pockct on the right to facilitate graft positioning. A troear is tunneled from tile 
abdominal wall pocket across the midline to exit through tile skin in a conve- 
nient position above the right iliac crest. The surgeon may slightly bend the 
troear to ease the passage across tile abdomen. After exiting tile skill, tile 
driveline is connected to tile troear and pulled througll the exit site. Tile t rocar 
is removed, and tile driveline is connected to tile controller, l-t 
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~[~ For tile aortic anastamosis, a partial occlusion clamp is placed on the ascending aorta. A 
lon~tudinal arteriotomy is made, and tile outflow graft is sewn to tile lateral ascending aorta 
using 5-0 polypropylene suture. After completion of tile at~astamosis, an18-gauge needle is placed 
in tile outflow graft between the aortic anastomosis and graft clamp. By temporarily releasing tile 
aortic partial occlusion clamp, the distal aortic graft is filled with blood and trapped air escapes 
through the 18-gauge needle. The aorta is re-clamped anti remaining air in the system is released 
through the 18-gauge needle by unclamping the proximal outflow graft and intermittently starting 
and stopping the pump. 
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After meticulous hemostasis, 1 or 2 drains are placed ill 
the mediastinum and 2 drains are idaced in the Immp pocket 
and posterior pericardium, l-t The device is covered with 
Preclude Pericardial Membrane (ePTFE) (WL Gore and 
Associates, Inc, Flagstaff, AZ) to facilitate subsequent expo- 
sure and protect he graft and heart at the time of transplan- 
tation. The incision is closed, and the driveline exit site is 
approximated and the line secured in place ~dth a suture. 
~" Tile aortic lmrtial occluding clamp is then removed and con- 
tinuous pumphag is beam at 7,500 qml. After completing de- 
ah-ing, tile 18-gauge needle is removed, and a pledgeted 4-0 
polypropylene suture is used to oversew tile needle hole. 1-t Ptmy) 
flows are 1)e~m at 7,500 rpm and adjusted to maint,'fin a cardiac 
index of appro:dmately 2.0 L/nrhdm ~ or greater. To nmintain 
sufficient pump flow, it is hnportant to ensure adecpmte preload. 
IIypovolemia and excessive pmnp speed eouhl resuh in ventrictdar 
collapse, dinthfished flows, mid suction of ,-fir. Using eehoeardiog- 
raphy, tim location of tile inflow eannula is viewed and the ventri- 
cles are assessed for vohune, fmmtion, and air. The hdlow eannula 
must be free of obstnlelion, gqlen placement of the eamnda is 
noted to be satisfactory and fows are adequate, the imlient is 
weaned from eardiolmhnonary b)]mss and protamine is adminis- 
tered to reverse hepaHnization. If needed, temporar T right heart 
bypass through the ptthnonary artery vent line can bc instituted 
before eompletely weaning off eardiopulmonary b pass. 
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POSTOPERATIVE  CARE 
During the initial postoperative period, care of patients 
implanted with the MicroMed DcBakey VAD follows 
standard guidelines for assist device patients. Patients 
receive routine antibiotic iwophylaxis. Right heart 
fimction is closely monitored by central venous pres- 
sure, pulmonary artery pressure, pump outpttt, and 
echocardiogram. The VAD's flowmeter allows for opti- 
mal settings of the pump avoiding suction or low flows. 
The pump speed (RPM) may be increased or decreased 
to adjust blood flow through the pump. The pump 
output is determined by the pump speed (RPM) and the 
difference in pressure (delta P) between intlow and 
outflow, l-t A reduction of the systemic vascular resis- 
tance leads to increased flows. 
For optimum putnp and cardiac fimction, adequate 
preload, afterload, ventrieular function, and cardiac 
rhythm are nmiutained. Inotropie support is continued 
postoperatively using iweoperative doses for at least 48 
hours to allow the right heart to adjust to the increased 
demand. 1-~ Weaning from intropic support is a gradual 
process that is determined by the patient's clinical 
condition. The routine heart failure medical treatment 
is continued. 
Anticoagulation is begun 24 to 48 hours postopera- 
tively with intravenous heparin after sanguineous 
drainage from the chest tubes has dimiuished, main- 
taining a lmrtial thromlmplastin time (PTT) of 60 to 80 
seconds. Thereafter,  patients are maintained on war- 
farin with or without a platelct inhibitor, t-t,a Generally, 
aspirin and dipyridanmle are prescribed if there are no 
clinical contraindications. The target International 
Normalized Ratio (INR) ranges from 2.5 to 3.0. If clot 
develops or embolizes to the pump, 100 mg of tissue 
plasminogen activator (TPA) may be infused over 1 
hour for treatment. TPA has also been used to treat 
late onset henmlysis in a few patients. If a cardiac 
catheterization is performed and the aortic valve is not 
opening, increasing inotropic support and decreasing 
the innnp speed (RPM) can aid in opening the valve for 
catheter passage. 
Because the MicroMed DeBakey VAD is an axial tlow 
putnp, continuous blood flow is generated. However, 
owing to persistent or improved right and left ventric- 
ular function, patients on the MicroMed DeBakey VAD 
develop some degree of pulsatility over time. 1-t,9 Pa- 
tients with a continuous flow pump nmy not lmve pal- 
pable pulses or blood pressures audible with sphyono- 
manometer and stethoscope. Paise oximeters nmy not 
measure peripheral oxygen saturations accurately. In- 
dwelling arterial catheters or Dopplers may be needed 
to evahtate blood iwessure and locate peripheral ar- 
teries, t-t 
The initial experience with the MicroMcd DeBakey 
VAD has demonstrated that nonpulsatile or less pulsa- 
tile blood flow is calmble of allowing secondary organ 
dysfunction to recover. After patients have recovered 
from the effects of surgery and heart failure, they arc 
started on an exercise program to improve their general 
heahh and conditioning. After extensive ducation of 
the patient and care~ver,  the patient can be discharged 
from the hospital, thus fitrther improving his or her 
quality of life. t~ 
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